Safety and effectiveness of percutaneous coronary intervention using rotational atherectomy and new-generation drug-eluting stents for calcified coronary artery lesions in patients with chronic kidney disease

Autor: Tawfiq Shahriar Huq, Dhiman Banik, Mir Nesaruddin Ahmed, Md. Habibur Rahman, Abdul Kayum Khan, Mohammad Badiuzzaman, Nazir Ahmed, Md. Abu Tareq Iqbal, Ashok Dutta, Md. Kalimuddin, Fazila-Tun-Nesa Malik
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Atherectomy
Coronary

medicine.medical_specialty
RD1-811
medicine.medical_treatment
Coronary Artery Disease
030204 cardiovascular system & hematology
Coronary Angiography
Percutaneous coronary intervention
Coronary artery disease
Lesion
03 medical and health sciences
0302 clinical medicine
Restenosis
Internal medicine
Chronic kidney disease
medicine
Diseases of the circulatory (Cardiovascular) system
Humans
030212 general & internal medicine
Renal Insufficiency
Chronic

Vascular Calcification
Retrospective Studies
business.industry
Stent
Rotational atherectomy
Drug-Eluting Stents
medicine.disease
Coronary Vessels
medicine.anatomical_structure
Treatment Outcome
RC666-701
Conventional PCI
Cardiology
Surgery
Original Article
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Kidney disease
Artery
Zdroj: Indian Heart Journal
Indian Heart Journal, Vol 73, Iss 3, Pp 342-346 (2021)
ISSN: 2213-3763
0019-4832
Popis: Aim Coronary artery calcification is an important factor influencing revascularisation outcomes in patients with chronic kidney disease (CKD). Lesion preparation using rotational atherectomy (RA) may help adequately modify calcified plaques and facilitate the achievement of optimal clinical outcomes in these patients. In this study, we assessed the safety and effectiveness of percutaneous coronary intervention (PCI) using RA followed by new-generation drug-eluting stent (DES) implantation in patients with CKD and calcified coronary artery disease (CAD). Methods and results From November 2014 to October 2019, a total of 203 patients with calcified CAD who underwent RA followed by second- or third-generation DES implantation at our centre were included in the study. Mild, moderate, and severe CKD was present in 38%, 55.5%, and 6.5% of the patients, respectively. Diffused coronary calcifications were present in 85%. Procedural success was 97.5% with minimal periprocedural complications. In-stent restenosis occurred in one patient (0.5%); major adverse cardiovascular and cerebrovascular events were reported in 22 patients (10.8%); cardiac death occurred in eight patients during follow-up. Conclusion Percutaneous coronary intervention using RA followed by second- or third-generation DES implantation is feasible and safe with high procedural success and low in-stent restenosis in CKD patients with calcified coronary lesions.
Databáze: OpenAIRE